Takeda has bought a licence for a coeliac disease drug from COUR Pharmaceuticals, after the US biotech announced supportive phase 2a trial data. Gastrointestinal diseases are one of the Japanese ...

Learn HTML, CSS, and JavaScript in simple terms with this beginner-friendly guide for 2026. Understand how these three core web technologies work together to build modern websites and create a strong ...

CHICAGO, June 18, 2026 (GLOBE NEWSWIRE) -- COUR Pharma, a clinical-stage biotechnology company developing first-in-class, antigen-specific immune tolerance therapies for autoimmune diseases, announced ...

Immerse yourself in history in the heart of Old Lyon, a UNESCO World Heritage site, at this local-loved landmark that dates from the 14th century. The restaurant alone is worth a trip. Rue du Boeuf is ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

It will release on the service early in the morning. The series is based on the popular manga by Inagaki Riichiro, which appeared in Shonen Jump Magazine. Here is everything you need to know about “Dr ...

Cour Pharmaceuticals, the Chicago-based clinical-stage biotechnology company, says its first patient has been dosed in the phase 1b/2a clinical trial of a treatment that it hopes will address ...

Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community. Issues are used to track todos, bugs, feature requests, and more.

Cour Pharmaceuticals, a local biotech startup that’s raised north of $100 million from investors, has inked a new licensing deal with a Roche subsidiary that’s valued at more than $900 million. The ...